BCL6 as a Marker of Uterine Lining Inflammation: A Retrospective Analysis of Treatment and Outcomes in Canada’s Largest User

The ReceptivaDx test, under an exclusive license with the University of North Carolina was validated by Cicero Diagnostics in conjunction with Pathology Consultants, Inc. of Greenville, SC. Pathology Consultants, Inc. is a laboratory certified under the Clinical Laboratory Improvement Amendments (CLIA). As with other laboratory-developed tests, this testing service has not been cleared or approved by the US FDA or any other federal regulatory agencies.